Production (Stage)
Amneal Pharmaceuticals, Inc.
AMRX
$7.16
-$0.03-0.42%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 92.27% | -39.16% | -1,886.83% | -8,426.17% | -25.17% |
| Total Depreciation and Amortization | 6.19% | 2.96% | -2.80% | -5.33% | -5.71% |
| Total Amortization of Deferred Charges | 118.62% | 208.38% | 53.96% | 69.08% | 92.63% |
| Total Other Non-Cash Items | -40.96% | -38.83% | 34.74% | 58.16% | 804.44% |
| Change in Net Operating Assets | 13.19% | 91.38% | 111.77% | 74.59% | -101.43% |
| Cash from Operations | 52.35% | -14.61% | 67.78% | 27.09% | 138.50% |
| Capital Expenditure | -41.66% | -28.93% | -6.87% | 12.61% | 4.32% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 71.18% | 34.56% | -1,264.55% | 5.82% | 22.82% |
| Cash from Investing | 20.95% | 8.95% | -60.59% | 15.83% | 12.90% |
| Total Debt Issued | -46.14% | -89.01% | 240.67% | 284.73% | 145.29% |
| Total Debt Repaid | -0.12% | 43.70% | -160.19% | -182.01% | -117.48% |
| Issuance of Common Stock | 149.48% | 155.88% | 156.37% | 97.87% | -13.07% |
| Repurchase of Common Stock | -195.71% | -234.40% | -234.24% | -233.59% | -191.98% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 91.03% | 91.48% | -146.18% | -372.42% | -520.21% |
| Cash from Financing | -2.23% | 0.37% | -87.76% | -162.86% | -284.52% |
| Foreign Exchange rate Adjustments | -50.40% | -1,636.92% | 98.50% | 90.78% | 74.07% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 116.87% | -69.77% | -5,978.17% | -496.10% | -51.89% |